Eyenovia Inc
EYEN6.970USD
+3.999+134.68%
收盘 06/17, 16:00（美东）报价延迟15分钟
19.73M总市值
亏损市盈率 TTM
关于 Eyenovia Inc 公司
Eyenovia, Inc. 是一家商业阶段的眼科制药技术公司，正在开发基于其 Optejet 平台的微剂量阵列打印疗法。该公司专注于 Mydcombi（托吡卡胺+苯肾上腺素眼用喷雾剂）的商业化，用于治疗散瞳，以及 0.05% 丙酸氯倍他索眼用混悬液，用于减轻眼科手术后的疼痛和炎症。其产品线包括 Mydcombi、丙酸氯倍他索和治疗方案 MicroPine 和 MicroLine。Mydcombi 是托吡卡胺-苯肾上腺素的固定组合配方，用于在诊断程序中以及在需要短期瞳孔扩张的情况下诱导散瞳。MicroPine 是其用于治疗进行性近视的局部疗法，这是一种与眼球病理性轴向延长和巩膜视网膜拉伸有关的疾病。 MicroLine 是该公司针对老花眼（一种与年龄相关的不可预防的晶状体硬化）的在研药物。
公司简介
公司代码EYEN
公司名称Eyenovia Inc
上市日期Jan 25, 2018
成立日期2014
CEOMr. Michael M. Rowe
员工数量13
证券类型Ordinary Share
年结日Jan 25
公司地址295 Madison Ave Ste 2400
城市NEW YORK
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编10017
电话18137669539
网址https://eyenovia.com/
公司代码EYEN
上市日期Jan 25, 2018
成立日期2014
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Tsontcho Ianchulev, M.D.
Dr. Tsontcho Ianchulev, M.D.
Director
Director
12.78K
+6.38%
Dr. Ellen R. Strahlman, M.D.
Dr. Ellen R. Strahlman, M.D.
Independent Director
Independent Director
1.71K
+81.68%
Mr. Michael M. Rowe
Mr. Michael M. Rowe
President, Chief Executive Officer, Principal Financial Officer, Treasurer, Company Secretary, Director
President, Chief Executive Officer, Principal Financial Officer, Treasurer, Company Secretary, Director
1.37K
-0.07%
Ms. Rachel Jacobson
Ms. Rachel Jacobson
Independent Director
Independent Director
1.30K
+143.63%
Dr. Ram Palanki, Pharm.D.
Dr. Ram Palanki, Pharm.D.
Independent Director
Independent Director
1.24K
+163.89%
Mr. Bren Kern
Mr. Bren Kern
Chief Operating Officer
Chief Operating Officer
31.00
--
Mr. Eric Ribner
Mr. Eric Ribner
Investor Relations
Investor Relations
--
--
Mr. Michael Geltzeiler
Mr. Michael Geltzeiler
Independent Director
Independent Director
--
--
Mr. Charles E. Mather, IV
Mr. Charles E. Mather, IV
Independent Chairman of the Board
Independent Chairman of the Board
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Tsontcho Ianchulev, M.D.
Dr. Tsontcho Ianchulev, M.D.
Director
Director
12.78K
+6.38%
Dr. Ellen R. Strahlman, M.D.
Dr. Ellen R. Strahlman, M.D.
Independent Director
Independent Director
1.71K
+81.68%
Mr. Michael M. Rowe
Mr. Michael M. Rowe
President, Chief Executive Officer, Principal Financial Officer, Treasurer, Company Secretary, Director
President, Chief Executive Officer, Principal Financial Officer, Treasurer, Company Secretary, Director
1.37K
-0.07%
Ms. Rachel Jacobson
Ms. Rachel Jacobson
Independent Director
Independent Director
1.30K
+143.63%
Dr. Ram Palanki, Pharm.D.
Dr. Ram Palanki, Pharm.D.
Independent Director
Independent Director
1.24K
+163.89%
Mr. Bren Kern
Mr. Bren Kern
Chief Operating Officer
Chief Operating Officer
31.00
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 6月3日 周二
更新时间: 6月3日 周二
持股股东
股东类型
持股股东
持股股东
占比
Avenue Capital Group
15.10%
UBS Financial Services, Inc.
6.91%
Virtu Americas LLC
0.80%
Ianchulev (Tsontcho)
0.44%
Citadel Advisors LLC
0.43%
Other
76.31%
持股股东
持股股东
占比
Avenue Capital Group
15.10%
UBS Financial Services, Inc.
6.91%
Virtu Americas LLC
0.80%
Ianchulev (Tsontcho)
0.44%
Citadel Advisors LLC
0.43%
Other
76.31%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
15.47%
Investment Advisor
6.97%
Research Firm
0.84%
Individual Investor
0.75%
Hedge Fund
0.43%
Other
75.54%
机构持股
更新时间: 3月3日 周一
更新时间: 3月3日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q1
142
82.72K
3.48%
-235.24K
2024Q4
145
87.40K
4.18%
-230.58K
2024Q3
143
274.49K
30.78%
+4.44K
2024Q2
142
255.79K
39.17%
+31.25K
2024Q1
131
203.15K
36.02%
-59.46K
2023Q4
121
244.77K
45.33%
+8.04K
2023Q3
122
223.92K
43.30%
+34.30K
2023Q2
116
185.43K
39.56%
+8.82K
2023Q1
83
152.79K
33.61%
-20.71K
2022Q4
82
156.27K
35.26%
-17.49K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Avenue Capital Group
30.62K
1.46%
+23.77K
+347.12%
Dec 31, 2024
Ianchulev (Tsontcho)
12.01K
0.57%
--
--
Dec 02, 2024
Geode Capital Management, L.L.C.
7.22K
0.34%
+242.00
+3.47%
Dec 31, 2024
Mather (Charles E IV)
1.19K
0.06%
-769.00
-39.36%
Dec 02, 2024
Strahlman (Ellen R)
939.00
0.04%
-769.00
-45.02%
Dec 02, 2024
Rowe (Michael M)
1.38K
0.07%
--
--
Dec 02, 2024
查看更多
持股ETF
更新时间: 6月6日 周五
更新时间: 6月6日 周五
机构名称
占比
Global X Russell 2000 Covered Call ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 Growth ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
iShares Micro-Cap ETF
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 Covered Call ETF
占比0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
ProShares UltraPro Russell2000
占比0%
Proshares Ultra Russell 2000
占比0%
iShares Russell 2000 ETF
占比0%
Global X Russell 2000 ETF
占比0%
Invesco NASDAQ Future Gen 200 ETF
占比0%
iShares Micro-Cap ETF
占比0%
ProShares Hedge Replication ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Jan 15, 2025
Merger
80<1
Jan 15, 2025
Merger
80<1
Jan 15, 2025
Merger
80<1
Jan 15, 2025
Merger
80<1
公告日期
类型
比率
Jan 15, 2025
Merger
80<1
Jan 15, 2025
Merger
80<1
Jan 15, 2025
Merger
80<1
Jan 15, 2025
Merger
80<1
